Olaris

Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration

placeWaltham, Massachusetts, United States calendar_todayFounded 2014 groups9 employees language myolaris.com

Registered entities

Social engagement

Social engagement: 5.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Innospark Ventures, Massachusetts Life Sciences Center.

Investor typeCountShare
Venture capital436%
Private equity19%
Other / undisclosed655%

Recent activity

18 Jun 2026
Event
ATC 2026
Coming soon